Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?Franz Heigl, Tobias Pflederer, Reinhard Klingel, et al.
Nature Clinical Practice. Cardiovascular Medicine|February 24, 2009
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary eventsBeate R Jaeger, Yvonne Richter, Dorothea Nagel, et al.
Atherosclerosis|October 22, 2025
Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-upReinhard Klingel, Ulrich Julius, Wanja M Bernhardt, et al.
Atherosclerosis. Supplements|November 4, 2017
Lipidological competence centres and networks: Future perspectives to improve healthcare of patients with disorders of lipid metabolismFranz Heigl, Tobias Pflederer, Volker Schettler, et al.
Frontiers in Cardiovascular Medicine|March 29, 2021
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 StudyWolfgang Ries, Jan Torzewski, Franz Heigl, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 5, 2022
The German Lipoprotein Apheresis Registry-Summary of the ninth annual reportVolker J J Schettler, Christian Peter, Thomas Zimmermann, et al.
Atherosclerosis. Supplements|November 4, 2017
Efficacy of lipid reduction with DALI and MONETWolfgang Ramlow, Eberhard Röseler, Franz Heigl, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 1, 2012
Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution CMR--a comparative analysisJochen M Grimm, Konstantin Nikolaou, Andreas Schindler, et al.
Atherosclerosis. Supplements|November 4, 2017
Safety aspects of lipidapheresis using DALI and MONET - Multicenter observational studyJustyna Kozik-Jaromin, Eberhard Röseler, Franz Heigl, et al.
Pageof 4